Invesaro

Stocks DLX Financial statements

Financial statements

DELUXE CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DELUXE CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue1,8491,9661,9982,0091,7912,0222,2382,1922,1222,133
Cost of revenue6687437928137318841,0321,0309951,003
Gross profit1,1811,2231,2061,1961,0601,1381,2061,1631,1261,131
Selling, general and administrative807830854892840941993956909873
Operating income367329231-18840.7142169161192232
Interest expense22.321.427.134.723.155.694.5126123122
Other non-operating income3.665.018.527.199.217.29.394.67.68.7
Pre-tax income340313213-21626.893.884.439.876.5119
Income tax11182.7638.0421.53118.813.623.636.9
Net income to minority interests000.090.140.140.10.10.1
Net income229230150-2245.2462.665.426.152.882.1
EBITDA458452362-62.2152291342331358370
EPS, basic5.235.313.56-5.200.121.481.520.601.201.83
EPS, diluted5.205.283.53-5.200.111.451.500.591.181.80
Shares, basic (weighted)43.44341.94341.942.44343.544.144.8
Shares, diluted (weighted)43.843.3424342.142.843.343.844.745.5
Dividend per share1.341.341.341.201.201.201.201.201.201.20

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents76.659.259.773.612341.240.47234.436.9
Receivables153150174163162198207191174188
Inventory40.242.246.439.940.134.952.342.136.433.5
Other current assets4139.138.644.816.823.52716.635.470.1
Total current assets398393450472507620704761612666
Property, plant and equipment86.984.690.396.588.7126125117112101
Lease right-of-use assets044.435.958.247.15949.443
Goodwill1,1061,1311,1617747031,4301,4311,4311,4231,423
Intangible assets410384360276247511459392331348
Long-term investments42.242.643.84545.947.247.861.96126.4
Other non-current assets125160196201209279260251237254
Total assets2,1842,2092,3051,9431,8423,0743,0773,0812,8312,864
Accounts payable107104107112117153157155165161
Accrued liabilities273277184179177217218191150191
Deferred revenue484754.346.142.152.64735.331.636.2
Short-term debt35.8440.790057.271.786.237.116.3
Total current liabilities416426392408412683752819626643
Long-term debt7236659118848401,6261,5731,5071,4661,413
Lease liabilities033.628.356.448.958.84939.8
Other non-current liabilities30.530.639.932.543.259.15368.867.534
Total liabilities1,3031,1941,3901,3961,3292,5002,4722,4762,2102,183
Total debt7597079108848401,6831,6441,5931,5031,429
Paid-in capital04.0917.657.479.299.1117138
Retained earnings8831,005927573495506519491489516
Other comprehensive income-50.4-37.6-56.6-47.9-41.4-31.5-37.3-30-29.9-18.5
Shareholders' equity8811,015915571
Minority interests00.140.280.420.520.20.3
Total equity8811,015915547513575604605621681
Total liabilities and equity2,1842,2092,3051,9431,8423,0743,0773,0812,8312,864
Shares outstanding43.442.939.942.14242.743.243.744.345

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income229230150-2245.3462.865.526.252.982.2
Depreciation and amortization91.6123131126111149173170166138
Stock-based compensation12.515.113.419.721.829.523.720.519.924.9
Deferred income tax1.89-39.2-11.4-41.2-5.4617.8-28.5-31.9-20.426.5
Change in receivables-23.45.28-16.85.61-2.71-8.86-13.77.43.5-19.9
Change in inventory2.24-0.64-3.644.84-11.3-1.84-19.16.32.52.7
Change in payables15.9-7.84.375.13-9.5222.86.024.910.5-3.9
Cash from operations319338339287218211192198194271
Capital expenditures-46.6-47.5-62.2-66.6-101-94.3-95.3
Acquisitions-240-139-192-8.250-95900
Purchases of investments-7.87-7.74-7.81-7.64-3.92-0.09-0.12
Sales and maturities of investments9.511.27.817.647.760.094.08800
Cash from investing-280-181-253-72.4-56.1-1,067-80.3-43.3-69.8-132
Debt issued5594031,2802423091,8856405841,808441
Debt repaid-442-454-1,079-268-353-1,030-681-639-1,890-519
Share buybacks-55.2-65-200-119-1400
Dividends paid-58.7-58.1-56.7-51.7-50.7-51.7-52.6-53.3-54.2-55.2
Cash from financing6-183-62.2-190-111913-48.6-37.7-267-137
Exchange rate effect2.365.37-7.645.443.69-1.1-10.73.2-6.11.7
Net change in cash48.2-2016.429.654.656.151.9121-1493.8
Free cash flow27329127722097.7100175
Interest paid2119.525.933.222.946.687.1116118112
Income taxes paid97.312588.360.824.718.838.646.546.430.9

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $24.33 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin52.5%Gross profit / revenue.
Operating margin11.9%Operating income / revenue.
EBITDA margin18.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin6.9%Pre-tax income / revenue.
Net margin4.8%Net income / revenue.
FCF margin9.9%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin14.3%Cash from operations / revenue.
Effective tax rate30.5%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)3.9%Net income / average total assets.
SG&A / revenue40.0%Selling, general and administrative expense / revenue.
Stock-based pay / revenue1.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.4%Capital expenditures / revenue.
D&A / revenue6.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y0.5%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-1.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y3.6%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y0.4%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-2.1%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y1.3%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y20.9%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y11.1%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y41.7%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y3.5%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y2.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y19.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y55.5%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y7.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y73.4%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y52.5%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y6.3%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y74.9%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y39.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y12.2%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y4.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y75.3%Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y0.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y0.0%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y0.0%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y1.2%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y-2.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y9.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y1.8%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y1.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y1.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.20xCurrent assets / current liabilities.
Quick ratio0.65x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.11x(Cash + short-term investments) / current liabilities.
Debt / assets52.8%Total debt / total assets.
Liabilities / assets72.4%Total liabilities / total assets.
Net debt$1.32BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA3.35xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage2.17xOperating income / interest expense.
Working capital$61.2MCurrent assets - current liabilities.
Goodwill and intangibles / assets68.3%(Goodwill + intangible assets) / total assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.82xRevenue / average total assets.
Fixed asset turnover14.9xRevenue / average property, plant and equipment.
Inventory turnover28.3xCost of revenue / average inventory.
Days inventory13 days365 x average inventory / cost of revenue.
Receivables turnover12.5xRevenue / average receivables.
Days sales outstanding29 days365 x average receivables / revenue.
Days payables54 days365 x average accounts payable / cost of revenue.
Cash conversion cycle-12 daysDays inventory + days sales outstanding - days payables.
FCF conversion207.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow31.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.17Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$45.53Revenue / diluted weighted shares.
FCF per share$4.51Free cash flow / diluted weighted shares.
Operating cash flow per share$6.53Cash from operations / diluted weighted shares.
Cash per share$0.76(Cash + short-term investments) / shares outstanding.
Payout ratio56.0%Dividends paid / net income, when net income is positive.
Dividends / FCF26.9%Dividends paid / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$1.12BShare price x shares outstanding.
Enterprise value$2.43BMarket cap + total debt - cash - short-term investments.
P/E11.1xMarket cap / net income. Only when net income is positive.
P/S0.53xMarket cap / revenue.
P/FCF5.34xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF3.68xMarket cap / cash from operations, when positive.
EV/Sales1.15xEnterprise value / revenue.
EV/EBIT9.69xEnterprise value / operating income, when both are positive.
EV/EBITDA6.19xEnterprise value / EBITDA, when both are positive.
EV/FCF11.6xEnterprise value / free cash flow, when both are positive.
FCF yield18.7%Free cash flow / market cap.
Earnings yield9.0%Net income / market cap (the inverse of P/E).
Dividend yield5.0%Dividends paid over the period / market cap.
Shareholder yield5.0%(Dividends paid + share buybacks) / market cap.
PEG1.77xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was DELUXE CORP's revenue in fiscal 2025?

DELUXE CORP reported revenue of $2.13B for fiscal 2025, 0.5% higher than the year before.

Was DELUXE CORP profitable in fiscal 2025?

Yes. Net income was $82.1M, a net margin of 3.8%.

How much free cash flow did DELUXE CORP generate in fiscal 2025?

Cash from operations of $270.6M minus capital expenditures of $95.3M left free cash flow of $175.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to DELUXE CORP